DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Siegel AB, Cohen EI, Ocean A. et al.
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma.
J Clin Oncol 2008;
26: 2992-2998
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.